132 related articles for article (PubMed ID: 34748781)
1. Development and validation of a non-invasive model for diagnosing HBV-related liver cirrhosis.
Zhang X; Huang P; Wang X; Zhou K; Chen F; Zhou C; Yu L; Lu Q; Zhou J; Hu J; Wang Z
Clin Chim Acta; 2021 Dec; 523():525-531. PubMed ID: 34748781
[TBL] [Abstract][Full Text] [Related]
2. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY
World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316
[TBL] [Abstract][Full Text] [Related]
3. Two-dimensional Shear-Wave Elastography Performance in the Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis B: Comparison with Serum Fibrosis Indexes.
Zhuang Y; Ding H; Zhang Y; Sun H; Xu C; Wang W
Radiology; 2017 Jun; 283(3):873-882. PubMed ID: 27982760
[TBL] [Abstract][Full Text] [Related]
4. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.
Cao X; Shang QH; Chi XL; Zhang W; Xiao HM; Sun MM; Chen G; An Y; Lv CL; Wang L; Nan YM; Chen CY; Tan ZN; Liu XE; Zhuang H
World J Gastroenterol; 2020 Mar; 26(10):1067-1079. PubMed ID: 32205997
[TBL] [Abstract][Full Text] [Related]
5. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.
Liu XD; Wu JL; Liang J; Zhang T; Sheng QS
World J Gastroenterol; 2012 Jun; 18(22):2784-92. PubMed ID: 22719186
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
[TBL] [Abstract][Full Text] [Related]
7. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
Li Q; Lu C; Li W; Huang Y; Chen L
Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
[TBL] [Abstract][Full Text] [Related]
8. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
[No Abstract] [Full Text] [Related]
9. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
Li Q; Ren X; Lu C; Li W; Huang Y; Chen L
Medicine (Baltimore); 2017 Mar; 96(12):e6336. PubMed ID: 28328813
[TBL] [Abstract][Full Text] [Related]
11. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
Li Q; Lu C; Li W; Huang Y; Chen L
Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
[TBL] [Abstract][Full Text] [Related]
12. A novel noninvasive algorithm for the assessment of liver fibrosis in patients with chronic hepatitis B virus infection.
Zhu MY; Zou X; Li Q; Yu DM; Yang ZT; Huang D; Chen J; Gong QM; Zhang DH; Zhang Y; Chen L; Chen PZ; Zhang XX
J Viral Hepat; 2017 Jul; 24(7):589-598. PubMed ID: 28130852
[TBL] [Abstract][Full Text] [Related]
13. [Clinical value of noninvasive method in diagnosing hepatic fibrosis about chronic HBV carriers].
Zhang XY; Qian J; Li P; Hu LH; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):332-336. PubMed ID: 29996199
[No Abstract] [Full Text] [Related]
14. Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients.
Dong M; Wu J; Yu X; Li J; Yang S; Qi X; Mao R; Zhang Y; Yu J; Zhu H; Yang F; Qin Y; Zhang J
Liver Int; 2018 Sep; 38(9):1562-1570. PubMed ID: 29314613
[TBL] [Abstract][Full Text] [Related]
15. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
Zeng DW; Dong J; Jiang JJ; Zhu YY; Liu YR
World J Gastroenterol; 2016 Nov; 22(43):9586-9594. PubMed ID: 27920479
[TBL] [Abstract][Full Text] [Related]
16. Identification of pseudo-immune tolerance for chronic hepatitis B patients: Development and validation of a non-invasive prediction model.
Li S; Li Z; Du H; Zao X; Gan D; Yang X; Li X; Xing Y; Ye Y
Front Public Health; 2023; 11():1137738. PubMed ID: 37089512
[TBL] [Abstract][Full Text] [Related]
17. [Establishment and preliminary application of serum Golgi protein 73 based noninvasive diagnostic model for compensated stage hepatitis B cirrhosis].
Zhai XW; Liu SH; Yao MJ; Qian XJ; Wen XJ; Xu Q; Zhao JM; Lu FM
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):47-52. PubMed ID: 32023699
[No Abstract] [Full Text] [Related]
18. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
19. A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis B.
Chen Y; Gong J; Zhou W; Jie Y; Li Z; Chong Y; Hu B
Biomed Res Int; 2020; 2020():6839137. PubMed ID: 32695818
[TBL] [Abstract][Full Text] [Related]
20. A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B.
Chen Y; Wang Y; Chen Y; Yu Z; Chi X; Hu KQ; Li Q; Tan L; Xiang D; Shang Q; Lei C; Chen L; Hu X; Wang J; Liu H; Lu W; Chi W; Dong Z; Wang X; Li Z; Xiao H; Chen D; Bai W; Zhang C; Xiao G; Qi X; Chen J; Zhou L; Sun H; Deng M; Qi X; Zhang Z; Qi X; Yang Y
Clin Transl Gastroenterol; 2019 May; 10(5):1-12. PubMed ID: 31033506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
